Literature DB >> 25286419

Erratum: Autologous fat transfer with in-situ mediation (AIM): a novel and compliant method of adult mesenchymal stem cell therapy.

Francesco M Marincola1.   

Abstract

Year:  2014        PMID: 25286419      PMCID: PMC4180154          DOI: 10.1186/s12967-014-0269-z

Source DB:  PubMed          Journal:  J Transl Med        ISSN: 1479-5876            Impact factor:   5.531


× No keyword cloud information.
After publication of this article [1] it was brought to the journal’s attention that David Morrow was unaware of the submission of this article in his name and did not consent to become an author. He points out that he was not involved in the creation of the article. Readers are also alerted that, in the absence of any evidence from an institutional investigation to confirm or refute the reliability of the data, there are ongoing concerns and this article’s findings should be interpreted with caution. Appropriate editorial action will be taken if further information becomes available.
  1 in total

1.  Autologous fat transfer with in-situ mediation (AIM): a novel and compliant method of adult mesenchymal stem cell therapy.

Authors:  Allan Y Wu; David M Morrow
Journal:  J Transl Med       Date:  2013-05-31       Impact factor: 5.531

  1 in total
  1 in total

1.  Expression of concern: Autologous fat transfer with in-situ mediation (AIM): a novel and compliant method of adult mesenchymal stem cell therapy.

Authors:  Francesco M Marincola
Journal:  J Transl Med       Date:  2014-11-04       Impact factor: 5.531

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.